review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | A. L. Goldstein | |
G. B. Thurman | |||
T. L. Low | |||
G. D. Marshall | |||
J. E. McClure | |||
S. K. Hu | |||
C. Chincarini | |||
P2860 | cites work | Cancer Research | Q326097 |
Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium | Q40652709 | ||
Detection of human T-lymphocyte antigens (HTLA antigens) on thymosin-inducible T-cell precursors | Q40676360 | ||
Effect of thymosin in vitro on T cell levels during radiation therapy.Correlations with radiation portal and initial T cell levels | Q41227836 | ||
The effect of antithymosin globulin on the recovery of T-cells in ATS-treated mice | Q43652631 | ||
Influence of Thymosin on Immunological Competence of Lymphoid Cells from Thymectomized Mice | Q44378141 | ||
Effect of thymosin on thymocyte proliferation and autoimmunity in NZB mice | Q44667639 | ||
Increase of cyclic GMP induced in murine thymocytes by thymosin fraction 5. | Q47967840 | ||
Reduction in the Incidence of Wasting Disease in Neonatally Thymectomized CBA/W Mice by the Injection of Thymosin | Q56802907 | ||
Free ubiquitin is a non-histone protein of trout testis chromatin | Q59062891 | ||
Influenza: Response of T-Cell Lymphopenia to Thymosin | Q66883463 | ||
Immunotherapy of cancer with thymosin | Q67058121 | ||
The complete amino acid sequence of ubiquitin, an adenylate cyclase stimulating polypeptide probably universal in living cells | Q67296048 | ||
The amino acid sequence of thymopoietin II | Q67298739 | ||
Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms | Q67323098 | ||
Thymosin induced changes in the cell cycle of lymphocytes from aging neonatally thymectomized rats | Q67865633 | ||
Stimulation of the hemagglutinin response of aged mice by cell-free lymphoid tissue fractions and bacterial endotoxin | Q70619306 | ||
Effects of the thymus lymphocytopoietic factor | Q70886244 | ||
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells | Q24564684 | ||
Cancer Treatment Reports | Q27710285 | ||
Thymosin activity in patients with cellular immunodeficiency | Q33899845 | ||
Biochemical characterisation of a serum thymic factor | Q34161628 | ||
Effect of thymosin and an antithymosin serum on allograft survival in mice | Q34653293 | ||
Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide | Q34674378 | ||
Purification and Biological Activity of Thymosin, a Hormone of the Thymus Gland | Q34714588 | ||
Preparation and properties of thymostatin, a new thymic inhibitor of DNA and RNA synthesis | Q35970926 | ||
Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice | Q35979311 | ||
Differentiation of T cells induced by preparations from thymus and by nonthymic agents | Q36335040 | ||
Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin) | Q36381898 | ||
ENHANCEMENT OF IN VIVO INCORPORATION OF LABELED PRECURSORS INTO DNA AND TOTAL PROTEIN OF MOUSE LYMPH NODES AFTER ADMINISTRATION OF THYMIC EXTRACTS | Q36397003 | ||
Thymosin Corrects the Abnormal DNA Synthetic Response of NZB Mouse Thymocytes | Q37451056 | ||
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone | Q37491187 | ||
Translation of mRNA from calf thymus in the wheat germ system: evidence for a precursor of thymosin alpha1 | Q37596356 | ||
Thymosin-induced reduction of "null cells" in peripheral-blood lymphocytes of patients with systemic lupus erythematosus | Q39327586 | ||
Thymosin: Basic Properties and Clinical Potential in the Treatment of Patients with Immunodeficiency Diseases and Cancer1 | Q39724918 | ||
Use of Thymosin in the Treatment of Primary Immunodeficiency Diseases and Cancer | Q39769727 | ||
In vitro and in vivo studies with thymosin in cancer patients | Q39794573 | ||
Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensitivity to picryl chloride and reversal of adult thymectomy effect by thymus extract | Q39802098 | ||
The effect of thymosin on patients with disseminated malignancies.A phase I study | Q39820846 | ||
The in vitro induction of differentiation of putative human stem cells by thymosin and agents that affect cyclic AMP | Q40145152 | ||
Thymosin immunotherapy in patients with small cell carcinoma of the lung. Correlation ofin vitro studies with clinical course | Q40216008 | ||
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer | Q40219084 | ||
Purification and properties of bovine thymosin | Q40319653 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | history and philosophy of science | Q5774812 |
P304 | page(s) | 33-48 | |
P577 | publication date | 1979-01-01 | |
P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
P1476 | title | Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation | |
P478 | volume | 332 |
Q70378746 | A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission |
Q40109999 | Acquired Immune Deficiency Syndrome, Leading to Opportunistic Infections, Kaposi's Sarcoma, and Other MalignanciesVolume 20, Issue 3 |
Q36331210 | Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V |
Q40109885 | Biological response modifiers and their promise in clinical medicine |
Q72662481 | Dialyzable leukocyte extract induces mast cell secretion |
Q70397198 | Dual action of leucocyte dialysates and of thymosin on the recovery of sheep-cell-rosetting capacity in trypsinized human lymphocytes |
Q38523318 | Effect of selected immunoregulatory agents on low-grade contact sensitivity |
Q71533344 | Gene expression of erythrocyte receptor: regulation of erythrocyte-receptor synthesis in T-lymphocytes |
Q70238241 | Generation of a monoclonal antibody against facteur thymique serique (FTS) |
Q70354935 | Identification of thymostimulin secreting cells in calf thymus by immunoperoxidase method |
Q72664922 | Immunohistochemical location of prothymosin alpha in regenerating human hepatocytes and hepatocellular carcinomas |
Q72832586 | Immunomodulation and therapeutic characterization of thymosin fraction five |
Q69879621 | In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma |
Q72102193 | Induction of T lymphocyte differentiation by thymic factors |
Q70230181 | Influenza and aging: Age-related changes and the effects of thymosin on the antibody response to influenza vaccine |
Q71071225 | Isolation of thymosin alpha 1 from thymosin fraction 5 of different species by high-performance liquid chromatography |
Q34465689 | Molecular markers and determinants of prostate cancer metastasis |
Q37673638 | Primary structure of rat thymus prothymosin alpha |
Q41951714 | Prothymosin alpha expression is associated to cell division in rat testis |
Q24605975 | Prothymosin alpha in human blood |
Q42805123 | Prothymosin alpha promotes cell proliferation in NIH3T3 cells. |
Q41990658 | Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS. |
Q40170298 | Resistance to Bacterial and Parasitic Infections in the Nutritionally Compromised Host |
Q70763973 | Resynthesis of trypsinized sheep red blood cell receptors on human lymphocytes: Comparison of the effects of immunopotentiators of biological and synthetic origin in vitro |
Q33846295 | Review of thymic hormones in cancer diagnosis and treatment |
Q72541193 | Selected phenotypic induction of null lymphocytes from mice with thymic and nonthymic agents |
Q72643359 | Sympathetic innervation of murine thymus and spleen: A comparative histofluorescence study |
Q44816754 | The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five) |
Q24628113 | The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA |
Q40217777 | The incredible shrinking chalone |
Q72817409 | The thymosins—preclinical and clinical studies with fraction V and alpha-i |
Q34452145 | Thymic hormones in cancer diagnostics and treatment |
Q72674016 | Thymosin Treatment Modulates Production of Interferon |
Q70330761 | Thymosin fraction 5 does not accelerate reconstitution of immunologic reactivity after human marrow grafting |
Q72764666 | Thymosin modulation of regulatory T cell function |
Q36003011 | Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes |
Search more.